Navigation Links
H1N1 Influenza Virus With Highest Replikin Count(TM) Since the 1918 Pandemic Identified in the U.S. and Austria
Date:4/7/2008

BOSTON, April 7, 2008 /PRNewswire/ -- Replikins Ltd. has found that the Replikin Count(TM) of the H1N1 strain of influenza virus has recently increased to 7.6 (plus/minus 1.4), its highest level since the 1918 H1N1 pandemic (p value less than 0.001). A rising Replikin Count of a particular influenza strain, indicating rapid replication of the virus, is an early warning which has been followed consistently by an outbreak of the specific strain. The current increase appears to be specific to H1N1; there was a concurrent 80% decline in the Replikin Count of H3N2, for instance.

The current H1N1 appears to be rapidly replicating simultaneously in the U.S. and Austria. It may succeed H5N1 as the leading candidate for the next expected overdue pandemic. However, the same virus replikin structures detected by FluForecast(R) software in all three previous pandemics, namely 1918 H1N1, 1957 H2N2, and 1968 H3N2, as well as in H5N1, have not yet been detected in the currently evolving H1N1.

There is evidence that many factors, including virus structure, host receptivity, and the environment, together with infectivity and rapid replication, need to converge for a pandemic to occur. For H5N1, the high human mortality rate, which peaked at over 80% in 2006-07 in Indonesia, as well as current low infectivity, both appear to limit H5N1's ability to produce a pandemic. Furthermore, the H5N1 rapid replication cycle which began in 1996 now appears to be over. The H5N1 virus produced less than 300 World Health Organization confirmed deaths over the past 10 years.

On the other hand, H1N1, with an estimated human mortality rate of only 2.5 to 10%, but with much higher infectivity, produced an estimated 50 million deaths in the 1918 pandemic. A number of countermeasures exist today which did not exist in 1918, however. Among these is Replikins' ability to manufacture synthetic vaccines based on current sequences, with a 7-day production turnaround.


'/>"/>

SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related biology technology :

1. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
2. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
3. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
4. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
5. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
6. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
7. Vical Presentation at Military Pandemic Influenza Workshop
8. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
9. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
10. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
11. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... 2012  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces ... and CEO, will be presenting at the Seventh ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The ... Neoepitopes Offer Attractive Targets for Active and Passive ... 21st at the Intercontinental Hotel in Boston from ...
(Date:5/16/2012)... LOUIS, May 16, 2012  Sigma-Aldrich announced today ... revolving credit facility that will mature on May ... million revolving credit facility that was scheduled to ... facility will provide back-up liquidity for the commercial ... purposes. Wells Fargo Securities LLC, Merrill ...
(Date:5/16/2012)... 2012 Reportlinker.com announces that ... available in its catalogue: , ... http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ This ... Biotechnology Instrumentation in US$ Million by ... Protein/Peptide Synthesizers, DNA Sequencers, Protein/Peptide Sequencers, ...
(Date:5/15/2012)... taken a step toward overcoming a key ... could bring optical advances including ultrapowerful microscopes, ... have shown how to create the metamaterials ... required, said Alexandra Boltasseva, a Purdue University ... , Using the metals is impractical for ...
Breaking Biology Technology:Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Global Biotechnology Instrumentation Industry 2Global Biotechnology Instrumentation Industry 3Global Biotechnology Instrumentation Industry 4Global Biotechnology Instrumentation Industry 5Global Biotechnology Instrumentation Industry 6Global Biotechnology Instrumentation Industry 7Global Biotechnology Instrumentation Industry 8Global Biotechnology Instrumentation Industry 9Global Biotechnology Instrumentation Industry 10Global Biotechnology Instrumentation Industry 11Global Biotechnology Instrumentation Industry 12Global Biotechnology Instrumentation Industry 13Global Biotechnology Instrumentation Industry 14Global Biotechnology Instrumentation Industry 15Global Biotechnology Instrumentation Industry 16Global Biotechnology Instrumentation Industry 17Global Biotechnology Instrumentation Industry 18Global Biotechnology Instrumentation Industry 19Global Biotechnology Instrumentation Industry 20New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3
... Feb. 23 GeneraMedix, Inc. announced,today that it ... its improved,formulation of epoprostenol sodium for the intravenous ... a biopharmaceutical company with,its headquarters in Allschwil/Basel, Switzerland. ... "This sale speaks directly ...
... a developer of a pharmacogenomic test to identify potential ... Lilly and Company under the trademark Xigris (R)), announced ... at the annual Invest Northwest Investor-CEO forum conference on ... is presented by the Washington Biotechnology & Biomedical Association ...
... NEW YORK, Feb. 23 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... plans to release,fourth quarter and full year 2008 financial ... , The Company will hold ... 9, 2009 to,discuss fiscal fourth quarter and full year ...
Other Biology Technology:GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 2GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 3Sirius Genomics to Present at Invest Northwest Conference 2
(Date:5/20/2012)... May 2012. The Stem Cells and Cancer Research ... the Vall d,Hebrn Institute of Oncology (VHIO) has ... to certain drugs used in clinical trials for ... also benefited from the collaboration with Professor Alberto ... Alberto Sols, Consejo Superior de Investigaciones Cientficas (IIB-CSIC-Madrid). ...
(Date:5/18/2012)... /PRNewswire-iReach/ -- With chronic diseases continuing to ... and research to find "cures" continuing to take ... "a few years away," a small but growing ... the human consciousness. A number of healing practices ... geometry, and intention, have emerged, embracing practices first ...
(Date:5/18/2012)... McCauley and Paul DeSalles did not set out to ... documented. But that,s exactly what they and a team ... and faculty did in a new study published ... light on how human disturbance of the natural world ... ecological interaction chains. This, in turn, highlights the need ...
Breaking Biology News(10 mins):Discovery of mechanisms predicting response to new treatments in colon cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 3Healing Method from Australia Addresses the Human Genome 2Stanford scientists document fragile land-sea ecological chain 2Vivakor Confirms Record Date of Stock Dividend 15068 1Vivakor Confirms Record Date of Stock Dividend 15068 2Vivakor Confirms Record Date of Stock Dividend 15068 3Amber Pharmacy Earns Accreditation From ACHC 6764 1Amber Pharmacy Earns Accreditation From ACHC 6764 2Cholesterol lowering drugs also may protect stem cell transplant patients from GVHD 62638 1Cholesterol lowering drugs also may protect stem cell transplant patients from GVHD 62638 2
... researchers led by the Smithsonian Institution has completed a ... the hobbit, a 3-foot-tall, 18,000-year-old hominin skeleton, discovered four ... study offers one of the most striking confirmations of ... remnant of one of the oldest human migrations to ...
... recently discovered that a chemical chain reaction that controls ... could mean the difference between normal growth and cancer. ... Cell, describes how organs can grow uncontrollably huge and ... , This chain reaction, a domino-like chain of events ...
... HONOLULU, Sept. 20 Women with low levels of vitamin ... a study led by the University of Pittsburgh Graduate School ... meeting of the American Society for Bone and Mineral Research ... professor of epidemiology, and colleagues evaluated patient data on 400 ...
Other Biology News:New research sheds light on 'Hobbit' 2Controlling for size may also prevent cancer 2Low vitamin D linked to higher risk of hip fracture 2
... The Tetrad 2 thermal cycler is a ... original Tetrad chassis, and it accepts the ... It delivers the same precision in thermal ... original Tetrad thermal cyclers, allowing easy transport ...
... The new Pierce ready-to-use 2-D gel marker ... analyst. This 2-D gel marker mix contains a ... offer important features of value to those who ... estimate pI and molecular weight values of proteins ...
... Tetrad thermal cycler expands the envelope ... DNA Engine cycler. It ... a footprint only twice the size, ... that run massive quantities of reactions, ...
The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
Biology Products: